Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PHAR · against 497 other Healthcare companies of similar size
Ranked #321 of 498 · scores higher than 36% of peers · safety percentile 40
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)42 peers with a safety percentile of 40–49, including PHAR · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 465 reported | 0.42× | 0.18× | 31% | 33% | |
| BetaLower is better · 471 reported | 0.07 | 0.45 | 85% | 33% | |
| Current ratioHigher is better · 487 reported | 3.01× | 2.85× | 53% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 317 | 10.6B CNY (≈$1.5B) | 41 | 43 | |
| 318 | 1.6B USD | 41 | 51 | |
| 319 | 95.6B INR (≈$1.1B) | 40 | 54 | |
| 320 | 7.4B HKD (≈$949M) | 40 | 49 | |
| 321 | 915M USD | 40 | 57 | |
| 322 | 7.1B CNY (≈$994M) | 40 | 54 | |
| 323 | 6.7B CNY (≈$941M) | 40 | 52 | |
| 324 | 142.9B INR (≈$1.7B) | 40 | 64 | |
| 325 | 13.8B SEK (≈$1.4B) | 39 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score